RadNet Acquires Gleamer SAS, Expanding AI Leadership and Global Reach
Summary
RadNet announced the acquisition of Gleamer SAS for approximately €230 million, making its DeepHealth subsidiary the largest global provider of radiology clinical AI solutions and enhancing operational efficiencies.
Key Events
-
Strategic Acquisition Announced
RadNet, through its DeepHealth subsidiary, acquired Gleamer SAS, a leading radiology AI company based in Paris, France.
-
Significant Purchase Price
The acquisition is valued at approximately €230 million, consisting of €215.0 million in cash at closing and a contingent payment of €15.0 million.
-
Global AI Leadership
This acquisition makes DeepHealth the largest provider of radiology clinical AI solutions worldwide, expanding its portfolio across all core imaging modalities.
-
Expected Operational Efficiencies
RadNet anticipates deploying Gleamer's solutions to drive cost efficiencies and improve patient care within its network by Q3 2026, particularly in X-ray imaging.
Analysis
RadNet's acquisition of Gleamer SAS for approximately €230 million significantly bolsters its DeepHealth subsidiary, positioning it as the largest provider of radiology clinical AI solutions globally. This strategic move expands DeepHealth's AI portfolio across multiple imaging modalities and is expected to drive substantial cost efficiencies and improve patient care within RadNet's network by the third quarter of 2026. The integration of Gleamer's high-growth, cloud-first solutions, which achieved over 90% compound annual growth in recurring revenue, is anticipated to accelerate automated diagnostics and enhance operational productivity, particularly in high-volume imaging workflows like X-ray.
At the time of this filing, RDNT was trading at $75.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $45.00 to $85.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.